» Articles » PMID: 16177111

Bordetella Type III Secretion Modulates Dendritic Cell Migration Resulting in Immunosuppression and Bacterial Persistence

Overview
Journal J Immunol
Date 2005 Sep 24
PMID 16177111
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic bacterial infection reflects a balance between the host immune response and bacterial factors that promote colonization and immune evasion. Bordetella bronchiseptica uses a type III secretion system (TTSS) to persist in the lower respiratory tract of mice. We hypothesize that colonization is facilitated by bacteria-driven modulation of dendritic cells (DCs), which leads to an immunosuppressive adaptive host response. Migration of DCs to the draining lymph nodes of the respiratory tract was significantly increased in mice infected with wild-type B. bronchiseptica compared with mice infected with TTSS mutant bacteria. Reduced colonization by TTSS-deficient bacteria was evident by 7 days after infection, whereas colonization by wild-type bacteria remained high. This decrease in colonization correlated with peak IFN-gamma production by restimulated splenocytes from infected animals. Wild-type bacteria also elicited peak IFN-gamma production on day 7, but the quantity was significantly lower than that elicited by TTSS mutant bacteria. Additionally, wild-type bacteria elicited higher levels of the immunosuppressive cytokine IL-10 compared with the TTSS mutant bacteria. B. bronchiseptica colonization in IL-10(-/-) mice was significantly reduced compared with infections in wild-type mice. These findings suggest that B. bronchiseptica use the TTSS to rapidly drive respiratory DCs to secondary lymphoid tissues where these APCs stimulate an immunosuppressive response characterized by increased IL-10 and decreased IFN-gamma production that favors bacterial persistence.

Citing Articles

and : Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations.

Miguelena Chamorro B, De Luca K, Swaminathan G, Longet S, Mundt E, Paul S Clin Microbiol Rev. 2023; 36(3):e0016422.

PMID: 37306571 PMC: 10512794. DOI: 10.1128/cmr.00164-22.


Bordetella bronchiseptica diguanylate cyclase BdcB inhibits the type three secretion system and impacts the immune response.

Belhart K, Sisti F, Gestal M, Fernandez J Sci Rep. 2023; 13(1):7157.

PMID: 37130958 PMC: 10154355. DOI: 10.1038/s41598-023-34106-x.


Bordetella bronchiseptica-Mediated Interference Prevents Influenza A Virus Replication in the Murine Nasal Cavity.

Luczo J, Soumana I, Reagin K, Dihle P, Ghedin E, Klonowski K Microbiol Spectr. 2023; :e0473522.

PMID: 36728413 PMC: 10100957. DOI: 10.1128/spectrum.04735-22.


Conquering the host: spp. and molecular regulators in lung infection.

Holban A, Gregoire C, Gestal M Front Microbiol. 2022; 13:983149.

PMID: 36225372 PMC: 9549215. DOI: 10.3389/fmicb.2022.983149.


Type III Secretion Injectosome and Effector Proteins.

Kamanova J Front Cell Infect Microbiol. 2020; 10:466.

PMID: 33014891 PMC: 7498569. DOI: 10.3389/fcimb.2020.00466.